[AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
Longo
Flavia
F
Oncologia Medica, Policlinico Umberto I, Roma.
Mansueto
Giovanni
G
D000328:Adult; D000368:Aged; D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D017326:Clinical Trials, Phase III as Topic; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D000077289:Letrozole; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D000077268:Pamidronate; D013629:Tamoxifen / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004164:Diphosphonates; D009570:Nitriles; D014230:Triazoles; D004002:Clodronic Acid; D013629:Tamoxifen; D000077384:Anastrozole; D000077289:Letrozole; D000077268:Pamidronate; D000077557:Ibandronic Acid